America Great Health
CIK 1098009fmd_1NQ8B39XJP6W40MFB3A14SYFV7Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2010 to Mar 31, 2026, 59 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | (1) | 0 | 0 | 0 |
| Research and development | 0 | – | – | – | – | – | – | – | – | – |
| Selling, general and administrative | 0 | 0 | – | – | – | 0 | 3 | 1 | 1 | 1 |
| Operating income | – | (0) | (0) | (0) | (0) | (0) | (5) | (0) | (1) | (0) |
| Interest expense | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | 0 | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) |
| Income before taxes | 0 | (0) | (0) | (0) | (0) | (0) | (5) | (1) | (1) | (1) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – |
| Net income from continuing operations | 0 | (0) | (0) | (0) | (0) | (0) | – | – | – | – |
| Net income | (1) | (1) | (0) | (0) | (0) | (0) | (5) | (1) | (1) | (1) |
| Net income to common shareholders | (1) | – | – | – | – | (0) | (5) | (1) | – | – |